Opinion|Videos|May 8, 2024

Key Results From the MajesTEC-1, MonumenTAL-1, and MagnetisMM-3 Trials

Sarah Rockwell, PharmD, BCOP, provides an overview of the safety and efficacy data of bispecific antibodies investigated in the MajesTEC-1, MonumenTAL-1, and MagnetisMM-3 trials, providing critical insights into the results of each study.

Episodes in this series


Latest CME